FPR2 and Alzheimer disease: Nonetheless, the data presented do suggest that this receptor would be a suitable target for antioxidative and metabolic therapeutic development for further AD research, particularly as the effects of Fpr2/3 stimulation were apparent when stimulation occurred after oAβ treatment.